| Next 10 |
Ad
BRKR News and Press Bruker Corporation
News | Bruker Corporation (NASDAQ:BRKR)
-
Bruker strengthens its applied markets leadership with RECIPE majority investment and unveils timsMetabo™, a next-generation platform for high-sensitivity small molecule analysis Bruker Corporation (NASDAQ: BRKR) today announced that its Applied Mass Spectrometry (Applied...
-
2025-06-03 07:33:06 ET More on Bruker Bruker Corp: Pan-Omics Dominance At A Margin Inflection Point Bruker Corporation 2025 Q1 - Results - Earnings Call Presentation Bruker Corporation (BRKR) Q1 2025 Earnings Call Transcript Bruker cut to Neural at Citi on po...
-
Acquisition further expands Bruker’s multiomics strategy with biocrates metabolomics kits and assays, and related software and research services Bruker Corporation (NASDAQ: BRKR) today announced the acquisition of biocrates life sciences ag, located in Innsbruck, Austria....
-
Breakthrough Athena Ion Processor (AIP) delivers up to 35% more peptide and 20% more protein identifications for highest sensitivity proteomics At the 73 rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) today announced significan...
-
A. New proteoElute nanoflow nLC system features ceramic valves, proteoTrap trapping columns, and TwinScape-enabled predictive maintenance technology B. Introducing new generation of PepSep Advanced nLC columns to further improve chromatographic resolution, sensitivity and proteomi...
-
Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will participate in the Jefferies Global Healthcare Conference in New York City with a fireside chat presentation scheduled for Wednesday, June 4 th , 2025 at 5:30 PM Eastern Time. A live audio webcast of the p...
-
Enabling Functional Proteoform Sequencing and Post-Translational Modification (PTM) Identification and Localization with Unprecedented Depth and Speed Beyond Protein Groups - Ushering in Era of ‘Proteoformics’ with New Scientific Lamp-Post Shining Light on Functional, Th...
-
Game-changing sensitivity for TIMS-enabled small molecule analysis 4D LC-TIMS-MS/MS separations and CCS measurements at scale for unprecedented specificity and annotation confidence Introducing the ‘digital metabolome archive’ for AI/ML scaling No...
-
2025-05-28 22:05:00 ET Summary Bruker operates in a duopoly with Thermo Fisher, serving critical life sciences and industrial markets, with diversified revenue and growing recurring sales. Despite macro headwinds and NIH budget cuts, Bruker trades at a mid-teens P/E, historically ...
-
2025-05-28 21:30:00 ET Summary We focus on enduring investment themes—AI and Life Sciences—amid policy uncertainty and market volatility, seeking opportunities where others see chaos. Our Q1 investments—TSMC, Bruker, and Lululemon—reflect conviction in ...
Stock Information
Get BRKR Alerts
News, Short Squeeze, Breakout and More Instantly...
Bruker Corporation Company Name:
BRKR Stock Symbol:
NASDAQ Market:
-0.46% G/L:
$38.255 Last:
365,522 Volume:
$38.70 Open:
$38.43 Close:
Bruker Corporation Website:
Ad
-
Bruker strengthens its applied markets leadership with RECIPE majority investment and unveils timsMetabo™, a next-generation platform for high-sensitivity small molecule analysis Bruker Corporation (NASDAQ: BRKR) today announced that its Applied Mass Spectrometry (Applied...
-
Acquisition further expands Bruker’s multiomics strategy with biocrates metabolomics kits and assays, and related software and research services Bruker Corporation (NASDAQ: BRKR) today announced the acquisition of biocrates life sciences ag, located in Innsbruck, Austria....
-
Breakthrough Athena Ion Processor (AIP) delivers up to 35% more peptide and 20% more protein identifications for highest sensitivity proteomics At the 73 rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) today announced significan...